Month: April 2022

MONTREAL, April 26, 2022 (GLOBE NEWSWIRE) — Sunshine Biopharma, Inc. (NASDAQ: “SBFM” and “SBFMW”) (the “Company” or “Sunshine Biopharma”), a pharmaceutical company focused on the research, development and commercialization of oncology and antiviral drugs, today announced that it entered into a securities purchase agreement with certain institutional and accredited investors for aggregate gross proceeds of approximately $19.5 million, before deducting fees to the placement agent and other offering expenses payable by the Company. In connection with the offering, the Company will issue 4,862,845 units and pre-funded units at a purchase price of $4.01 per unit, priced at-the-market under Nasdaq rules. Each unit and pre-funded unit consist of 1 share of common stock or common stock equivalent, and 2 non-tradable warrants, each warrant...

ZURICH Glattbrugg, 26 April 2021 – gategroup Holding AG (“gategroup”, the “Company” and together with its subsidiaries, the “Group”), published today its full-year results and Annual Report for the financial year ending 31 December 2021. Revenues were increased by 35% to CHF 2.097 billion in 2021 (vs. CHF 1.552 billion in 2020). EBITDA was positive, with a profit of CHF 60.5 million in 2021 (vs. a loss of CHF -256.7 million in 2020). Cash and cash equivalents were at CHF 246.6 million as per December 31, 2021 compared to CHF 302.9 million at the end of 2020. “With a solid increase in business volume in airline catering towards the end of 2021 and the continuing growth of our food services business,” says Christoph Schmitz, CEO of gategroup, “the group is well positioned to benefit from the continuing recovery of the aviation industry in...

SOUTH SAN FRANCISCO, Calif., April 25, 2022 (GLOBE NEWSWIRE) — Nkarta, Inc. (Nasdaq: NKTX), a biopharmaceutical company developing engineered natural killer cell therapies to treat cancer, today announced the pricing of an underwritten public offering of 13,333,334 shares of its common stock at a price to the public of $15.00 per share. The Company has granted the underwriters a 30-day option to purchase up to 2,000,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions. All shares in the offering are to be issued and sold by Nkarta. The offering is expected to close on or about April 28, 2022, subject to customary closing conditions. Gross proceeds to Nkarta from this offering are approximately $200 million, before deducting underwriting discounts and commissions and...

Enabling real-time data streams for data analytics, starting with Synopsys’ Silicon Lifecycle Management platform Highlights:New ACS Nexus enables real-time data streaming from distributed test floors across the semiconductor supply chain for the analytics solutions of customers and third-parties  Strategic collaboration between Synopsys and Advantest enables real-time data analytics in Synopsys’ SiliconDash. Advantest’s ACS open solution ecosystem is expanded through Synopsys’ Silicon Lifecycle Management platform.             TOKYO, April 25, 2022 (GLOBE NEWSWIRE) — Leading semiconductor test equipment supplier Advantest Corporation (TSE: 6857) and Synopsys (Nasdaq: SNPS), a leading provider of EDA software and data analytics solutions for the semiconductor ecosystem, have enabled real-time data analytics in Synopsys’ SiliconDash...

ROSH HA’AYIN, Israel, April 25, 2022 (GLOBE NEWSWIRE) — Kornit Digital Ltd. (“Kornit”) (Nasdaq: KRNT), a worldwide market leader in sustainable, on-demand, digital fashionx and textile production technologies, announced today that it will release its financial results for the first quarter ended March 31, 2022, on Wednesday, May 11, 2022, prior to the opening of the market. The Company will host an earnings conference call and webcast reviewing these results and its operations on Wednesday, May 11th at 8:30 am ET. This conference call will be broadcast live and can be accessed by all interested parties through Kornit’s website, www.kornit.com, in the “Investors” section. The dial-in information for the live call is:Live Call: 1-877-407-0792 (US/Canada Toll-Free)International: 1-201-689-8263 or 1 809-406-247 (Israeli...

Company Expects to Complete its 10-K Filing Early this Week Radnor, PA, April 25, 2022 (GLOBE NEWSWIRE) — RADNOR, PA, April 25, 2022 – BM Technologies, Inc. (NYSE American: BMTX) (the “Company”), one of the largest digital banking platforms and Banking-as-a-Service (BaaS) providers, received notice on April 18, 2022 from NYSE Regulation stating that the Company is not in compliance with the continued listing standards of the NYSE American LLC (the “Exchange”) under the timely filing criteria set forth in Section 1007 of the NYSE American Company Guide (the “Company Guide”). The non-compliance results from the Company’s failure to timely file its Annual Report on Form 10-K for the year ended December 31, 2021 (the “Form 10-K”) (the “Filing Deficiency”).  In accordance with Section 1007 of the Company Guide, the Company will have...

NEW ALBANY, Ohio, April 25, 2022 (GLOBE NEWSWIRE) — CVG (NASDAQ: CVGI) will hold its quarterly conference call on Thursday, May 5, 2022, at 10:00 a.m. ET, to discuss first quarter 2022 financial results. CVG will issue a press release and presentation prior to the conference call. Toll-free participants dial (833) 235-5650 using conference code 4591137. International participants dial (647) 689-4139 using conference code 4591137. This call is being webcast and can be accessed through the “Investors” section of CVG’s website at ir.cvgrp.com where it will be archived for one year. A telephonic replay of the conference call will be available for a period of two weeks following the call. To access the replay, toll-free callers can dial (800) 585-8367 using access code 4591137 and international callers can dial (416) 621-4642 using...